Announcements Trials

Browse Landscape

Phase

Status

Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 8 Neoplasm Metastasis 7 Multiple Myeloma 6 Prostatic Neoplasms 5 Pain 3 Uterine Cervical Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 Bone Neoplasms 2 Uterine Cervical Dysplasia 1 Urologic Neoplasms 1 Small Cell Lung Carcinoma 1 Precancerous Conditions 1 Pleural Effusion, Malignant 1 Osteoporosis 1 Neuroblastoma 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Neoplasm, Residual 1 Lung Neoplasms 1 Kidney Neoplasms 1 Humoral Hypercalcemia Of Malignancy 1 Hematologic Neoplasms 1 Giant Cell Tumors of Bone 1 Giant Cell Tumor of Bone 1 Disease Progression 1 Carcinoma, Ductal, Breast 1 Breast Neoplasms, Male 1 Bone Diseases, Metabolic 1 Adenocarcinoma 1

Interventions

Zoledronic Acid 1 Denosumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Giant Cell Tumor of Bone × Zoledronic Acid × Clear all

NCT00889590 2016-01-26

HR-GCT

Leiden University Medical Center

Phase 2 Terminated

Giant Cell Tumor of Bone

Data powered by HemOnc (CC BY 4.0) Colophon ⚡